A Novel Cancer Vaccine Strategy Based on HLA-A*0201 Matched Allogeneic Plasmacytoid Dendritic Cells

PLoS ONE - United States
doi 10.1371/journal.pone.0010458
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Targeting Dendritic Cells: A Promising Strategy to Improve Vaccine Effectiveness

Clinical and Translational Immunology
AllergyImmunologyNursing
2016English

An Innovative Plasmacytoid Dendritic Cell Line-Based Cancer Vaccine Primes and Expands Antitumor T-Cells in Melanoma Patients in a First-In-Human Trial

OncoImmunology
OncologyAllergyImmunology
2020English

Plasmacytoid Dendritic Cells Mediate Oral Tolerance

Immunity
Infectious DiseasesAllergyImmunology
2008English

Induction of Antigen-Specific Cytotoxic T Lymphocytes by Fusion Cells Generated From Allogeneic Plasmacytoid Dendritic and Tumor Cells

International Journal of Oncology
Cancer ResearchOncology
2014English

Plasmacytoid Dendritic Cells Drive Acute Exacerbations of Asthma

Journal of Allergy and Clinical Immunology
AllergyImmunology
2018English

Identification of a Novel Conserved HLA-A*0201-restricted Epitope From the Spike Protein of SARS-CoV

BMC Immunology
Immunology
2009English

Plasmacytoid Dendritic Cells Promote Systemic Sclerosis With a Key Role for TLR8

Science Translational Medicine
Medicine
2018English

Plasmacytoid Dendritic Cells Migrate in Afferent Skin Lymph

Journal of Immunology
AllergyImmunology
2008English

Plasmacytoid Dendritic Cells Lead the Charge Against Tumors

Journal of Clinical Investigation
Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy